Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
6.84
+0.08 (1.18%)
At close: Feb 4, 2026
SHE:002412 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 127.88 | 128.02 | 51.13 | 145.41 | 90.31 | 103.56 |
Trading Asset Securities | 357.16 | 244.12 | 203.87 | 135.82 | 49.24 | - |
Cash & Short-Term Investments | 485.03 | 372.14 | 255 | 281.23 | 139.55 | 103.56 |
Cash Growth | 30.80% | 45.94% | -9.33% | 101.52% | 34.75% | -24.19% |
Accounts Receivable | 446.03 | 425.03 | 352.52 | 320.57 | 272.88 | 277.62 |
Other Receivables | 16.38 | 0.88 | 0.63 | 11.96 | 1.86 | 35.15 |
Receivables | 462.42 | 442 | 359.99 | 332.53 | 274.74 | 312.77 |
Inventory | 208.15 | 222.88 | 231.12 | 246.62 | 103.37 | 84.43 |
Prepaid Expenses | - | 6.9 | 3.8 | - | 1.23 | 2.71 |
Other Current Assets | 89.89 | 79.25 | 46.16 | 5.03 | 16.51 | 23.99 |
Total Current Assets | 1,245 | 1,123 | 896.07 | 865.4 | 535.41 | 527.46 |
Property, Plant & Equipment | 463.87 | 489.16 | 515.61 | 439.45 | 470.75 | 485.63 |
Long-Term Investments | 771.82 | 855.75 | 841.81 | 781.35 | 707.95 | 628.39 |
Goodwill | 14.79 | 14.79 | 14.79 | 14.79 | 53.03 | 92.66 |
Other Intangible Assets | 28.94 | 29.3 | 29.54 | 33.72 | 42.58 | 52.1 |
Long-Term Deferred Tax Assets | 2.22 | 2.42 | 2.5 | 2.04 | 2.11 | 2.36 |
Long-Term Deferred Charges | 15.15 | 14.41 | 15.13 | 15.71 | 16.42 | 17.14 |
Other Long-Term Assets | 20.21 | 18.23 | 21.04 | 138.47 | 283.03 | 82.92 |
Total Assets | 2,562 | 2,547 | 2,336 | 2,291 | 2,111 | 1,889 |
Accounts Payable | 25.99 | 41.62 | 41.11 | 43.63 | 51.44 | 38.12 |
Accrued Expenses | 17.79 | 48.31 | 62.58 | 66.83 | 48.31 | 30.54 |
Short-Term Debt | 55.05 | 84.51 | 95.12 | 120.15 | 131.79 | 178 |
Current Income Taxes Payable | 6.77 | 6.23 | 11.64 | 4.61 | 4.52 | 0.34 |
Current Unearned Revenue | 0.97 | 2.72 | 6.48 | 7.02 | 1.71 | 3.52 |
Other Current Liabilities | 170.76 | 134.93 | 138.51 | 138 | 113.33 | 22.91 |
Total Current Liabilities | 277.34 | 318.32 | 355.42 | 380.24 | 351.11 | 273.43 |
Long-Term Unearned Revenue | 23.46 | 24.54 | 16.81 | 15.03 | 16.22 | 18.12 |
Long-Term Deferred Tax Liabilities | 0.87 | 1 | 1.22 | 1.54 | 1.66 | 2.37 |
Total Liabilities | 301.66 | 343.85 | 373.46 | 396.81 | 368.99 | 293.92 |
Common Stock | 503.2 | 503.2 | 503.2 | 503.2 | 503.2 | 503.2 |
Additional Paid-In Capital | 234.12 | 234.12 | 234.12 | 234.12 | 232.77 | 202.31 |
Retained Earnings | 1,518 | 1,436 | 1,215 | 1,161 | 993.7 | 897.86 |
Comprehensive Income & Other | 5.37 | 30.45 | 10.34 | -4.5 | 12.63 | -8.65 |
Total Common Equity | 2,261 | 2,203 | 1,963 | 1,894 | 1,742 | 1,595 |
Shareholders' Equity | 2,261 | 2,203 | 1,963 | 1,894 | 1,742 | 1,595 |
Total Liabilities & Equity | 2,562 | 2,547 | 2,336 | 2,291 | 2,111 | 1,889 |
Total Debt | 55.05 | 84.51 | 95.12 | 120.15 | 131.79 | 178 |
Net Cash (Debt) | 429.98 | 287.63 | 159.88 | 161.08 | 7.76 | -74.44 |
Net Cash Growth | 47.75% | 79.90% | -0.74% | 1975.89% | - | - |
Net Cash Per Share | 0.85 | 0.57 | 0.32 | 0.32 | 0.02 | -0.15 |
Filing Date Shares Outstanding | 503.2 | 503.2 | 503.2 | 503.2 | 503.2 | 503.2 |
Total Common Shares Outstanding | 503.2 | 503.2 | 503.2 | 503.2 | 503.2 | 503.2 |
Working Capital | 968.15 | 804.85 | 540.65 | 485.17 | 184.3 | 254.03 |
Book Value Per Share | 4.49 | 4.38 | 3.90 | 3.76 | 3.46 | 3.17 |
Tangible Book Value | 2,217 | 2,159 | 1,919 | 1,846 | 1,647 | 1,450 |
Tangible Book Value Per Share | 4.41 | 4.29 | 3.81 | 3.67 | 3.27 | 2.88 |
Buildings | - | 647.47 | 644.48 | 531.89 | 533.67 | 499.4 |
Machinery | - | 228.7 | 223.66 | 221.69 | 218.69 | 207.09 |
Construction In Progress | - | 10.8 | 9.08 | 6.09 | 5.26 | 26.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.